Diagnostic Accuracies of Plasma P-Tau205, P-Tau212, and P-Tau217 Immunoassays in Alzheimer Disease
Open Access
- 1 December 2026
- journal article
- Published by Wolters Kluwer Health in Neurology Open Access
- Vol. 2 (4) , e000175
Abstract
Background and ObjectivesEarly changes in tau phosphorylation (p-tau) at selected sites including p-tau217 and p-tau212, in the initial phases of amyloid-beta (Aβ) plaque accumulation, are thought ...Keywords
This publication has 37 references indexed in Scilit:
- Pittsburgh plasma p‐tau217: Classification accuracies for autosomal dominant and sporadic Alzheimer's disease in the communityAlzheimer's & Dementia, 2025
- Plasma p‐tau immunoassays in clinical research for Alzheimer's diseaseAlzheimer's & Dementia, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- CSF p-tau205: a biomarker of tau pathology in Alzheimer’s diseaseActa Neuropathologica, 2024
- CSF tau phosphorylation at sites 217 and 205 mediate the relationship between PET amyloid and downstream AD markersAlzheimer's & Dementia, 2022
- Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative DisordersJAMA, 2020
- A Phosphorylation‐Induced Turn Defines the Alzheimer’s Disease AT8 Antibody Epitope on the Tau ProteinAngewandte Chemie International Edition, 2015
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approachActa Neuropathologica, 2011
- Racial differences in coronary artery calcification are not attributed to differences in lipoprotein particle sizes: The Heart Strategies Concentrating on Risk Evaluation (Heart SCORE) StudyAmerican Heart Journal, 2007
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004